Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Divalproex for Maintenance Treatment of PTSD
NCT00203385Phase 4Terminated
- Sponsor
- Tuscaloosa Research and Education Advancement Corporation
- Start
- May 2003
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of divalproex sodium in post-traumatic stress disorder (PTSD), sponsored by Tuscaloosa Research and Education Advancement Corporation. Primary endpoint: Clinician Administered PTSD Scale at 24 weeks. Started May 2003; status: terminated.
02
Drugs
divalproex sodium
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00203385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00203385.